Can-Fite BioPharma (CANF) Shares Outstanding (Entity) (2013 - 2025)
Can-Fite BioPharma (CANF) Shares Outstanding (Entity) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 253.35 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 62.54 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 399.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 113.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 133.73 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 252.88 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 218.28 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 575.47 Mn |
| 10 | Can-Fite BioPharma | 2.76 Mn | -8.79 Mn | - | 823,104.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.33 Mn |
| Jun 30, 2025 | 750,620.00 |
| Dec 31, 2024 | 612,618.00 |
| Jun 30, 2024 | 426,268.00 |
| Dec 31, 2023 | 425,587.00 |
| Sep 30, 2023 | 266,155.00 |
| Jun 30, 2023 | 264,464.00 |
| Mar 31, 2023 | 259,352.00 |
| Dec 31, 2022 | 179,464.00 |
| Sep 30, 2022 | 17,946.00 |
| Jun 30, 2022 | 17,946.00 |
| Mar 31, 2022 | 17,946.00 |
| Dec 31, 2021 | 12,168.00 |
| Sep 30, 2021 | 11,350.00 |
| Jun 30, 2021 | 11,000.00 |
| Mar 31, 2021 | 10,646.00 |
| Dec 31, 2020 | 7,885.00 |
| Sep 30, 2020 | 7,114.00 |
| Jun 30, 2020 | 5,609.00 |
| Mar 31, 2020 | 4,432.00 |